Skip to main content
SpringerLink
Log in

Hemorrhagic Cystitis

  • Chapter
Urological Emergencies

Part of the book series: Current Clinical Urology ((CCU))

Abstract

Hemorrhagic cystitis (HC) is a common urological disorder, presenting in 6.5% of patients following pelvic radiation therapy and up to 25% of patients receiving alkylating chemotherapeutic agents. HC can be devastating, with high morbidity and mortality despite aggressive interventions (1). Massive urothelial hemorrhage may involve both upper and lower urinary tracts (2), leading to acute renal failure that requires emergent urological interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 179.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cheng C, Foo KT. Management of severe chronic radiation cystitis. Ann Acad Med Singapore 1992; 21(3): 368–371.

    PubMed  CAS  Google Scholar 

  2. Wong TM, Yeo W, Chan LW, Mok TS. Hetnorrhagic pyelitis, ureteritis and cystitis secondary to cyclophosphamide: case report and review of literature. Gynecol Oncol 2000; 76(2): 223–225.

    Article  PubMed  CAS  Google Scholar 

  3. Levenback C, Eifcl PJ, Burke TW, Morris M, Gershenson DM. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol 1994; 55(2): 206–210.

    Article  PubMed  CAS  Google Scholar 

  4. Sell A, Bertelsen K, Andersen JE, Stroyer I, Panduro J. Randomized study of whole-abdomen irradiation vs pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 1990; 37(3): 367–373.

    Article  PubMed  CAS  Google Scholar 

  5. deVries CR, Freiha FS. Hemorrhagic cystitis: a review. J Urol 1990; 143(1): 1–9.

    PubMed  CAS  Google Scholar 

  6. Sencer SF, Haake RJ, Weisdorf DJ. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications. Transplantation 1993; 56(4): 875–879.

    Article  PubMed  CAS  Google Scholar 

  7. Stillwell TJ, Benson RC Jr. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer 1988; 61(3); 451–457.

    Article  PubMed  CAS  Google Scholar 

  8. Brugieres L, Hartmann O, Travagli JP, et al. Hemorrhagic cystitis following high-dose chemo therapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. J Clin Oncol 1989; 7(2): 194–199.

    PubMed  CAS  Google Scholar 

  9. Mahjoubi M, Azab M, Ghosn M, Theodore C, Droz JP. Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer. Cancer Invest 1990; 8(5): 477–481.

    Article  PubMed  CAS  Google Scholar 

  10. Sarosy G. Ifosfamide — pharmacologic overview. Semin Oncol 1989; 16(1, suppl 3): 2–8.

    PubMed  CAS  Google Scholar 

  11. Shanholtz C. Acute life-threatening toxicity of cancer treatment. Crit Care Clin 2001; 17(3): 483–502.

    Article  PubMed  CAS  Google Scholar 

  12. Pihusch R, Salat C, Schmidt E, et al. Hemostatic complications in hone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 2002; 74(9): 1303–1309.

    Article  PubMed  Google Scholar 

  13. Hong WK, Nicaise C. Lawson R. et al. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group. J Clin Oncol 1989; 7(4): 450–456.

    PubMed  CAS  Google Scholar 

  14. Stillwell TJ, Benson RC Jr, DeRemee RA, McDonald TJ, Weiland LH. Cyclophosphamide-induced bladder toxicity in Wegener’s granulomatosis. Arthritis Rheum 1988; 31(4): 465–470.

    Article  PubMed  CAS  Google Scholar 

  15. Stillwell TJ, Benson RC Jr, Burgert EO Jr. Cyclophosphamide-induced hemorrhagic cystitis in Ewing’s sarcoma. J Clin Oncol 1988; 6(1): 76–82.

    PubMed  CAS  Google Scholar 

  16. Williams SF, Bitran JD, Hoffman PC, et al. High-dose, multi-alkylator chemotherapy with autologous bone marrow reinfusion in patients with advanced non-small cell lung cancer. Cancer 1989; 63(2): 238–242.

    Article  PubMed  CAS  Google Scholar 

  17. Heyn R, Raney RB Jr, Hays DM, Tefft M, Gehan E, Webber B, Maurer HM. Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol 1992; 10(4): 614–623.

    PubMed  CAS  Google Scholar 

  18. Allen JC. Complications of chemotherapy in patients with brain and spinal cord tumors. Pediatr Neurosurg 1991; 17(4): 218–224.

    Article  PubMed  Google Scholar 

  19. Crilley P, Topolsky D, Bulova S, Bigler R, Brodsky I. Bone marrow transplantation following busulfan and cyclophosphamide for acute myelogenous leukemia. B one Marrow Transplant 1990; 5(3): 187–191.

    CAS  Google Scholar 

  20. Islam R, Isaacson BJ, Zickerman PM, Ratanawong C, Tipping SJ. Hemorrhagic cystitis as an unexpected adverse reaction to temozolomide: case report. Am J Clin Oncol 2002; 25(5): 513–514.

    Article  PubMed  Google Scholar 

  21. Mylonakis E, Goes N, Rubin RH, Cosimi AB, Colvin RB, Fishman JA. BK virus in solid organ transplant recipients: an emerging syndrome. Transplantation 2001; 72(10): 1587–1592.

    Article  PubMed  CAS  Google Scholar 

  22. Reploeg MD, Storch GA, Clifford DB. BK virus: a clinical review. Clin Infect Dis 2001; 33(2): 191–202.

    Article  PubMed  CAS  Google Scholar 

  23. Iwamoto S, Azuma E, Hori H, et al. BK virus-associated fatal renal failure following late-onset hemorrhagic cystitis in an unrelated bone marrow transplantation. Pediatr Hematol Oncol 2002; 19(4): 255–261.

    Article  PubMed  Google Scholar 

  24. Bielorai B, Shulman LM, Rechavi G, Toren A. CM V reactivation induced BK virus-associated late onset hemorrhagic cystitis after peripheral blood stem cell transplantation. Bone Marrow Trans plant 2001; 28(6): 613–614.

    Article  CAS  Google Scholar 

  25. Akiyama H, Kurosu T, Sakashita C, et al. Adenovirus is a key pathogen in hemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32(9): 1325–1330.

    Article  PubMed  CAS  Google Scholar 

  26. Echavarria MS, Ray SC, Ambinder R, Dumler JS. Charache P. PCR detection of adenovirus in a bone marrow transplant recipient: hemorrhagic cystitis as a presenting manifestation of disseminated disease. J Clin Microbiol 1999; 37(3): 686–689.

    PubMed  CAS  Google Scholar 

  27. Boubenider S, Hiesse C, Marchand S, Hafi A, Kriaa F, Charpentier B. Post-transplantation polyomavirus infections. J Nephrol 1999; 12(1): 24–29.

    PubMed  CAS  Google Scholar 

  28. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98(6): 1971–1978.

    Article  PubMed  CAS  Google Scholar 

  29. Azzi A, Fanci R, Bosi A, et al. Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. Bone Marrow Transplant 1994; 14(2): 235–240.

    PubMed  CAS  Google Scholar 

  30. Londergan TA, Walzak MP. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation. J Urol 1994; 151(4): 1013–1014.

    PubMed  CAS  Google Scholar 

  31. Barouch DH, Faquin WC, Chen Y, Koralnik IK, Robbins GK, Davis BT. BK virus-associated hemorrhagic cystitis in a human immunodeficiency virus-infected patient. Clin Infect Dis 2002; 35(3): 326–329.

    Article  PubMed  Google Scholar 

  32. Lopez AE, Rodriguez S, Flores I. Management of ischemic hemorrhagic cystitis with hyperbaric oxygen therapy. Undersea Hyperb Med 2001; 28(1): 35–36.

    PubMed  CAS  Google Scholar 

  33. Koh LP. Boon’s disease: hemorrhagic cystitis in conjunction with massive exfoliation of degenerated urothelial cells (apoptosis?) during intercontinental flights in an otherwise healthy person. Diagn Cytopathol 2001; 25(6): 361–364.

    Article  Google Scholar 

  34. Messing EM, Catalona W. Urothelial tumors of the urinary tract. In: Campbell’s Urology, 7th ed. (Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ, eds.), Saunders, Philadelphia, PA, 1998, Vol. 3, pp. 2327–2410.

    Google Scholar 

  35. Pedersen-Bjergaard J, Ersboll J, Hansen VL, et al. Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin’s lymphoma. N Engl J Med 1988; 318(16): 1028–1032.

    Article  PubMed  CAS  Google Scholar 

  36. Kondo M, Kojima S, Kato K, Matsuyama T. Late-onset hemorrhagic cystitis after hemotopoietic stem cell transplantation in children. Bone Marrow Transplant 1998; 22(10): 995–998.

    Article  PubMed  CAS  Google Scholar 

  37. Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT) — incidence and effect on survival. A quantitative analysis in 1402 patients. Blood 1998; 91(4): 1469–1477.

    PubMed  CAS  Google Scholar 

  38. Avidor Y, Nadu A, Matzkin H. Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. Urology 2000; 55(1): 22–24.

    Article  PubMed  CAS  Google Scholar 

  39. Worawattanakul S, Semelka RC, Kelekis NL. Post radiation hemorrhagic cystitis: MR findings. Magn Reson Imaging 1997; 15(9): 1103–1106.

    Article  PubMed  CAS  Google Scholar 

  40. Cartoni C, Arcese W, Avvisati G, Corinto L, Capua A, Meloni G. Role of ultrasonography in the diagnosis and follow-up of hemorrhagic cystitis after bone marrow transplantation. Bone Marrow Transplant 1993; 12(5): 463–467.

    PubMed  CAS  Google Scholar 

  41. Katz A, Epelman S, Anelli A, et al. A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regime: sustained efficiency and simplified administration. J Cancer Res Clin Oncol 1995; 121(2): 128–131.

    Article  PubMed  CAS  Google Scholar 

  42. Meisenberg B, Lassiter M, Hussein A, Ross M, Vredenburgh JJ, Peters WP. Prevention of hem orrhagic cystitis after high-dose alkylating agent chemotherapy and autologous bone marrow support. Bone Marrow Transplant 1994; 14(2): 287–291.

    PubMed  CAS  Google Scholar 

  43. Luce JK, Simons JA. Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis. Med Pediatr Oncol 1988; 16(6): 372–374.

    Article  PubMed  CAS  Google Scholar 

  44. Haselberger MB, Schwinghammer TL. Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Ann Pharmacother 1995; 29(9): 918–921.

    PubMed  CAS  Google Scholar 

  45. Reinhold-Keller E, Mohr J, Christophers E, Nordmann K, Gross WL. Mesna side effects which imitate vasculitis. Clin Investig 1992; 70(8): 698–704.

    Article  PubMed  CAS  Google Scholar 

  46. Vose JM, Reed EC, Pippert GC, et al. Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial. J Clin Oncol 1993; 11(7): 1306–1310.

    PubMed  CAS  Google Scholar 

  47. Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna vs hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 1991; 9(11): 2016–2020.

    PubMed  CAS  Google Scholar 

  48. Ballen KK, Becker P, Levebvre K, et al. Safety and cost of hyperhydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients. Oncology 1999; 57(4): 287–292.

    Article  PubMed  CAS  Google Scholar 

  49. Moon RE, Camporesi EM. Hyperbaric oxygen therapy: from the 19th to the 21st century. Respir Care Clin N Am 199; 5(1): 1–5.

    Google Scholar 

  50. Hampson NB, chair and ed. Hyperbaric Oxygen Therapy: 1999 Committee Report. Undersea and Hyperbaric Medical Society, Kensington, MD, 1999.

    Google Scholar 

  51. Robertson PW, Hart BB. Assessment of tissue oxygenation. Resp Care Clin N Am 1999; 5(2): 221–263.

    CAS  Google Scholar 

  52. Marx RE, Ehler WJ, Tayapongsak P, et al. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg 1990; 160(5): 519–524.

    Article  PubMed  CAS  Google Scholar 

  53. Shoshani O, Shupak A, Ullmann Y, et al. The effect of hyperbaric oxygenation on the viability of human fat injected into nude mice. Plas Reconstr Surg 2000; 106(6): 1390–1396.

    Article  CAS  Google Scholar 

  54. Thorn JJ, Kallehave F, Westergaard P, et al. The effect of hyperbaric oxygen on irradiated oral tissues: transmucosal oxygen tension measurements. J Oral Maxillofac Surg 1997; 55(10): 1103–1107.

    Article  PubMed  CAS  Google Scholar 

  55. Matthew R, Rajan N, Josefson L, et al. Hyperbaric oxygen therapy for radiation induced hemorrhagic cystitis. J Urol 1999; 161(2): 435–437.

    Article  Google Scholar 

  56. Bevers RF, Bakker DJ, Kurth KH. Hyperbaric oxygen treatment for hemorrhagic radiation cystitis. Lancet 1995; 346(8978): 803–805.

    Article  PubMed  CAS  Google Scholar 

  57. Norkool DM, Hampson NB, Gibbons RP, et al. Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol 1993; 150(2 Pt 1): 332–334.

    PubMed  CAS  Google Scholar 

  58. Weiss JP, Mattel DM, Neville EC, et al. Primary treatment of radiation-induced cystitis with hyperbaric oxygen: 10-year experience. J Urol 1994; 151(6): 1514–1517.

    PubMed  CAS  Google Scholar 

  59. Crew JP, Jephcott CR, Reynard JM. Radiation-induced hemorrhagic cystitis. Eur Urol 2002; 40(2): 111–123.

    Article  Google Scholar 

  60. Ennis RD. Hyperbaric oxygen for the treatment of radiation cystitis and proctitis. Curr Urol Rep 2000; 3(3): 229–231.

    Article  Google Scholar 

  61. O’Reilly KJ, Hampson NB, Corman JM. Hyperbaric Oxygen in Urology. AUA Update Series Lesson 4, Vol. 21. American Urological Association, Houston, TX, 2002, pp. 26–31.

    Google Scholar 

  62. Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med 2002; 29(1): 4–30.

    PubMed  CAS  Google Scholar 

  63. Corman JM, McClure RD, Pritchett TR, Kozlowski P, Hampson NB. Treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen. J Urol 2003; 169: 2200–2202.

    Article  PubMed  Google Scholar 

  64. Kanwar VS, Jenkins JJ, Mandrell BN. Aluminium toxicity following intravesical alum irrigation for hemorrhagic cystitis. Med Pediatr Oncol 1996; 27(1): 64–67.

    Article  PubMed  CAS  Google Scholar 

  65. Sarnak MJ, Long J, King AJ. Intravesicular formaldehyde instillation and renal complications. Clin Nephrol 1999; 51(2): 122–125.

    PubMed  CAS  Google Scholar 

  66. Stefanini M, English HA, Taylor AE. Safe and effective, prolonged administration of epsilon-aminocaproic acid in bleeding from the urinary tract. J Urol 1990; 143(3): 559–561.

    PubMed  CAS  Google Scholar 

  67. Ippoliti C, Przepiorka D, Mehra R, et al. Intravesical Carboprost for the treatment of hemorrhagic cystitis after marrow transplantation. Urology 1995; 46(6): 811–815.

    Article  PubMed  CAS  Google Scholar 

  68. Laszlo D, Bosi A, Guidi S, et al. Prostaglandin E2 bladder instillation for the treatment of hemorrhagic cystitis after allogenic bone marrow transplantation. Haematologica 1995; 80(5): 421–425.

    PubMed  CAS  Google Scholar 

  69. Trigg ME, O’Reilly J, Rumelhart S, Morgan D, Holida M. de Alarcon P. Prostaglandin E1 bladder instillations to control severe hemorrhagic cystitis. J Urol 1990; 143(1): 92–94.

    PubMed  CAS  Google Scholar 

  70. Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR. Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogenic hematopoietic cell transplantation. Bone Marrow Transplant 2000; 26(8): 899–901.

    Article  PubMed  CAS  Google Scholar 

  71. Miyamura K, Hamaguchi M, Taji H, et al. Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogenic marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant 2000; 25(5): 545–548.

    Article  PubMed  CAS  Google Scholar 

  72. Seabra C, Perez-Simon JA, Sierra M, et al. Intramuscular vidarabine therapy for polyomavirus-associated hemorrhagic cystitis following allogenic hemopoietic stem cell transplantation. Bone Marrow Transplant 2000; 26(11): 1229–1230.

    Article  PubMed  CAS  Google Scholar 

  73. Miller J, Burfield GD, Moretti KL. Oral conjugated estrogen therapy for treatment of hemorrhagic cystitis. J Urol 1994; 151(5): 1348–1350.

    PubMed  CAS  Google Scholar 

  74. Demesmay K, Tissot E, Bulabois CE, et al. Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four cases. Transplantation, 2002; 74(8): 1190–1192.

    Article  PubMed  CAS  Google Scholar 

  75. Vela-Ojeda J, Tripp-Villanueva F, Sanchez-Cortes E, et al. Intravesical rhGM-CSF for the treat ment of late onset hemorrhagic cystitis after bone marrow transplant. Bone Marrow Transplant 1999; 24(12): 1307–1310.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Urology and Renal Transplantation, Virginia Mason Medical Center, Seattle, WA

    Kian Tai Chong MBBS, MRCSEd & John M. Corman MD

Authors
  1. Kian Tai Chong MBBS, MRCSEd
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John M. Corman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Washington School of Medicine and Harborview Medical Center, Seattle, WA

    Hunter Wessells MD, FACS

  2. University of California School of Medicine and San Francisco General Hospital, San Francisco, CA

    Jack W. McAninch MD, FACS

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Chong, K.T., Corman, J.M. (2005). Hemorrhagic Cystitis. In: Wessells, H., McAninch, J.W. (eds) Urological Emergencies. Current Clinical Urology. Humana Press. https://doi.org/10.1385/1-59259-886-2:201

Download citation

  • DOI: https://doi.org/10.1385/1-59259-886-2:201

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-256-8

  • Online ISBN: 978-1-59259-886-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation